Serotonin receptors: their key role in drugs to treat schizophrenia.
about
Teratogenic mechanisms of medical drugsToward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationshipsSerotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patientsF15063, a potential antipsychotic with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. I. In vitro receptor affinity and efficacy profileGuinea pig hippocampal 5-HT(1E) receptors: a tool for selective drug developmentThe behavioral pharmacology of hallucinogens5-HT3 receptorsAntipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanismsMultiple D2 heteroreceptor complexes: new targets for treatment of schizophreniaNeuroleptic Malignant Syndrome: A Review from a Clinically Oriented PerspectiveA Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical CorrelatesPreclinical models of antipsychotic drug action.Recent progress in understanding subtype specific regulation of NMDA receptors by G Protein Coupled Receptors (GPCRs)Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates TreatmentBlonanserin ameliorates phencyclidine-induced visual-recognition memory deficits: the complex mechanism of blonanserin action involving D₃-5-HT₂A and D₁-NMDA receptors in the mPFC.Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and managementAsenapine: a novel psychopharmacologic agent with a unique human receptor signatureClozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical reviewOpinion: NK3 receptor antagonists: the next generation of antipsychotics?Synthesis and evaluation of a series of 2-substituted-5-thiopropylpiperazine (piperidine)-1,3,4-oxadiazoles derivatives as atypical antipsychoticsPatterns of genetic variation and the role of selection in HTR1A and HTR1B in macaques (Macaca)Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophreniaAntipsychotic drugs on maternal behavior in rats.Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis.Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.Low dose morphine adjuvant therapy for enhanced efficacy of antipsychotic drug action: potential involvement of endogenous morphine in the pathophysiology of schizophrenia.Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A/2C receptors.Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapinePsilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.Administration of clozapine to a mother rat potentiates pup ultrasonic vocalization in response to separation and re-separation: contrast with haloperidol.Behavioral effects of clozapine: involvement of trace amine pathways in C. elegans and M. musculusAnxiolytic-like property of risperidone and olanzapine as examined in multiple measures of fear in rats.Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspectsPharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.Modulation of midbrain dopamine neurotransmission by serotonin, a versatile interaction between neurotransmitters and significance for antipsychotic drug action.Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine.Manganese-enhanced magnetic resonance imaging reveals increased DOI-induced brain activity in a mouse model of schizophrenia.Spiperone enhances intracellular calcium level and inhibits the Wnt signaling pathway.
P2860
Q22337136-FBD7DE54-31FB-4432-8FB2-DDEA86237144Q24297642-992FA20A-DB59-4C4C-85C5-EC7D0EA08A18Q24554505-9619FFF9-5BED-456D-B501-EA83BF6371E4Q24564964-26D12BDE-5E2A-4FF5-86EE-869FAE4DED20Q24643885-A7D60DE6-4F79-4971-9A8C-4E7C54B66819Q24645656-7BC0A0FB-D711-4BFE-BEA0-6A3CDAEA6047Q24648000-BA756AB7-1EC8-4FE0-8A38-AA7861AC6E4AQ26745506-386C3A59-B3D6-4692-B7C0-466E02E7549FQ26747736-163D97F4-15B7-4E11-9022-7D960398BC4FQ26786284-A6C44690-9D1C-4779-A4DF-7BDFC7008616Q26786354-A7A1E5BC-7E58-4CEE-A7CB-D8D0A5FC1E00Q26827502-477FF675-C4BC-4FA3-9FE1-7D720580DF47Q27006067-0DE0D92B-CDAA-4D2F-95A1-9FCBB1556E3BQ27015872-F8536256-A8FD-412E-93E8-C11BAF6C6FA8Q27311205-05C79D2C-3B93-49EF-8510-7B7461DE0977Q28268128-DEE84C18-7365-4A10-988A-5355FD9876C4Q28270767-EC2BB9FA-1448-44C7-A935-0FFC24C684B7Q28274106-7026FD8B-F5FD-490A-9ADC-A04C90C39B00Q28286127-FD3E5DDD-FF57-446A-89CE-2503A29F27F4Q28483019-F8C3B7BB-E1A9-41F0-BAFA-81D271CA94D5Q28652363-BE68A36D-BF32-44DD-99E0-C9BA700AB583Q30365347-973766FE-27EB-47DA-B0FD-8850128E6CACQ30371933-8CE2D777-F16A-40D2-877E-28B97151163FQ30375083-84446534-01E1-41B7-AE6F-FDC33F65BB97Q30395943-95A1319B-D7D8-4C09-97CF-F0F22595C4B5Q30421478-CC6FBB81-3C28-4096-9618-2CDFE3EB142DQ30437188-7B76EC72-AA72-47A6-AD56-D3DF8102446AQ30455274-0742A9D9-AF9B-48DF-9584-E93A8CA597C2Q30455893-9916B8D3-D098-4D11-B45F-5D27F35DEF2BQ30458533-D0B900F0-7CD7-47CA-B1DD-106284AEFF0EQ30458761-2DEFDC04-E9B6-46EA-96F6-D9D6BBD53028Q30463447-2E046FEF-8CDB-41D9-8ACF-F934D21C6B42Q30466971-F1A6D953-D8F4-45AB-A46C-783BE59CDFE6Q30475709-8305546C-05DF-49DB-BE5C-E37E1688510CQ30476813-DCE7E96B-4C41-4325-A117-FAD037BD5AB0Q30493133-D32E9245-CE62-41E7-8B41-61B633006D91Q30493995-D77E6357-9BF6-41D4-9925-E09E213976D0Q30524246-BEC413D1-9EBC-4063-AB00-D1B23DF2888CQ30581184-BF6E07AD-B877-48BB-8D55-63CD3D5839DBQ30931951-D41E5716-45F5-407E-91CA-E6AA359B1731
P2860
Serotonin receptors: their key role in drugs to treat schizophrenia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Serotonin receptors: their key role in drugs to treat schizophrenia.
@ast
Serotonin receptors: their key role in drugs to treat schizophrenia.
@en
type
label
Serotonin receptors: their key role in drugs to treat schizophrenia.
@ast
Serotonin receptors: their key role in drugs to treat schizophrenia.
@en
prefLabel
Serotonin receptors: their key role in drugs to treat schizophrenia.
@ast
Serotonin receptors: their key role in drugs to treat schizophrenia.
@en
P2093
P1476
Serotonin receptors: their key role in drugs to treat schizophrenia.
@en
P2093
Herbert Y Meltzer
Junji Ichikawa
Yasuhiro Kaneda
P304
P356
10.1016/J.PNPBP.2003.09.010
P577
2003-10-01T00:00:00Z